| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Anoxemia
[description not available] | 0 | 2.48 | 2 | 0 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 2.97 | 4 | 0 |
Hypoxia
Sub-optimal OXYGEN levels in the ambient air of living organisms. | 0 | 2.48 | 2 | 0 |
Pregnancy
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. | 0 | 2.31 | 1 | 0 |
Cognitive Decline
[description not available] | 0 | 2.21 | 1 | 0 |
Cognition Disorders
Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. | 0 | 2.21 | 1 | 0 |
Cognitive Dysfunction
Diminished or impaired mental and/or intellectual function. | 0 | 2.21 | 1 | 0 |
Allergic Encephalomyelitis
[description not available] | 0 | 2.44 | 2 | 0 |
Innate Inflammatory Response
[description not available] | 0 | 2.53 | 2 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 2.53 | 2 | 0 |
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) | 0 | 2.83 | 3 | 0 |
Adenocarcinoma, Basal Cell
[description not available] | 0 | 2.05 | 1 | 0 |
Breast Cancer
[description not available] | 0 | 2.05 | 1 | 0 |
Adenocarcinoma
A malignant epithelial tumor with a glandular organization. | 0 | 2.05 | 1 | 0 |
Breast Neoplasms
Tumors or cancer of the human BREAST. | 0 | 2.05 | 1 | 0 |
Retrolental Fibroplasia
[description not available] | 0 | 2.01 | 1 | 0 |
Neovascularization, Optic Disc
[description not available] | 0 | 2.01 | 1 | 0 |
Retinopathy of Prematurity
A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed) | 0 | 2.01 | 1 | 0 |
Retinal Neovascularization
Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina. | 0 | 2.01 | 1 | 0 |
Benign Neoplasms
[description not available] | 0 | 2.02 | 1 | 0 |
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 2.02 | 1 | 0 |
Cancer, Radiation-Induced
[description not available] | 0 | 2.9 | 1 | 0 |
Fibrosarcoma
A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) | 0 | 2.9 | 1 | 0 |
MS (Multiple Sclerosis)
[description not available] | 0 | 1.99 | 1 | 0 |
Weight Reduction
[description not available] | 0 | 1.99 | 1 | 0 |
Multiple Sclerosis
An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) | 0 | 1.99 | 1 | 0 |
Weight Loss
Decrease in existing BODY WEIGHT. | 0 | 1.99 | 1 | 0 |